Purified capsular polysaccharide preparations from Streptococcus pneumoniae that are used for vaccine production typically contain residual levels of C-polysaccharide (C-Ps). Residual C-Ps is typically found in one of two forms, either chemically linked to the capsular polysaccharide (bound) or present by itself (free). Two analytical methods have been developed and applied to determine the relative percentages of the two C-Ps forms present in various capsular polysaccharide preparations. Both methods differentiate the two forms of C-Ps according to the difference of their hydrodynamic sizes. One method is based on labeling C-Ps with a fluorescent tag and separating the two forms of C-Ps by high-performance size exclusion chromatography with on-line refractive index and fluorescence detection, and the other method is based on measuring self-diffusion rates of the two forms of C-Ps by nuclear magnetic resonance (NMR) and quantifying each form with deconvolution. Both methods were evaluated for relative accuracy, precision, and ease of application, and they were found to provide comparable results for a large number of pneumococcal polysaccharide preparations. These analyses, combined with other quantitative NMR measurement of total C-Ps in the polysaccharide powder, provide a more refined means of evaluating the amount of each form of C-Ps in polysaccharide preparations targeted for vaccine production
NMR, capsular, characterization, polysaccharide, Streptococcus, Streptococcus pneumoniae, linked, Research, form, capsular polysaccharide, level, production, nuclear, nuclear magnetic resonance, resonance, method, difference, purified, methods, chromatography, preparation, CPS, measurement, vaccine, fluorescent, pneumococcal, bound, size, C-polysaccharide, quantification, fluorescence, quantitative, C polysaccharide, detection, free, application, exclusion, labeling
The publication contains the following compound(s):|
Show legend Show as text |
| New query | Export IDs | Home | Help |
Execution: <1 sec
Found